| Literature DB >> 32924505 |
Yuanyuan Yang1, Yingjie Yu1,2, Hao Chen3, Xiangxi Meng4, Wen Ma1, Meng Yu1, Ziyuan Li5, Changhui Li5, Haile Liu6, Xiaodong Zhang6, Haihua Xiao2, Zhiqiang Yu1.
Abstract
Killing tumor cells with a visualized system is a promising strategy in tumor therapy to achieve minimal side effects and high efficiency. Herein, a theranostic nanomedicine (AuNCs-Pt) is developed based on nanocarrier gold nanoclusters (AuNCs) with bifunctions of both NIR-I/NIR-II imaging and glutathione-scavenging abilities. AuNCs-Pt possesses NIR-II imaging capability on a fatal high-grade serous ovarian cancer (HGSOC) model in the deep abdomen, thus facilitating it to be a promising tool for monitoring platinum transportation. Meanwhile, AuNCs-Pt depletes intracellular glutathione to minimize platinum detoxification, effectively maximizing the chemotherapeutic efficacy of platinum. AuNCs-Pt is used to eradicate the tumor burden in this study on a HGSOC model and a patient-derived tumor xenograft model of hepatocellular carcinoma, suggesting great potential for clinical visualized therapy and platinum drug sensitization.Entities:
Keywords: glutathione scavenging; patient-derived xenograft model; second near-infrared bioimaging; theranostics; visualized tumor therapy
Mesh:
Substances:
Year: 2020 PMID: 32924505 DOI: 10.1021/acsnano.0c05541
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881